Serina Therapeutics CFO granted 123,019 stock options
Serina Therapeutics, Inc. reported that Chief Financial Officer Gregory S. Curhan received a compensation grant of stock options covering 123,019 shares of common stock at an exercise price of $1.89 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Serina Therapeutics, Inc. reported that Chief Financial Officer Gregory S. Curhan received a compensation grant of stock options covering 123,019 shares of common stock at an exercise price of $1.89 per share. The options vest over four years, with 12/48ths vesting one year after the Vesting Commencement Date and 1/48th each month thereafter, and expire on May 21, 2036. Following this award, Curhan holds stock options for 123,019 underlying shares directly.
Insider Trade Summary
Grant/Award: 123,019 shares
Grant/Award
1 txn
Insider
CURHAN GREGORY S
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 123,019 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 123,019 contracts (Direct)
Footnotes (1)
- F1. Unless otherwise terminated as provided in the optionee's option agreement, 12/48ths of the shares subject to the option shall vest twelve months after the Vesting Commencement Date, and 1/48th of the shares subject to the option shall vest on the same calendar day of each subsequent month thereafter until the shares subject to the option are fully vested.
Key Figures
Option grant size: 123,019 shares
Exercise price: $1.89 per share
Expiration date: May 21, 2036
+3 more
6 metrics
Option grant size
123,019 shares
Underlying common stock in CFO stock option award
Exercise price
$1.89 per share
Strike price of CFO stock option grant
Expiration date
May 21, 2036
Option term end date for CFO grant
Post-grant option holdings
123,019 options
Total stock options held directly after this award
Initial vesting tranche
12/48ths of shares
Vest twelve months after Vesting Commencement Date
Ongoing vesting rate
1/48th per month
Monthly vesting after initial twelve-month cliff
Key Terms
Stock Option (right to buy), exercise price, Vesting Commencement Date, vesting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price: "1.8900""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Vesting Commencement Date financial
"twelve months after the Vesting Commencement Date, and 1/48th"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
vesting financial
"shares subject to the option shall vest twelve months after"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2036-05-21T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Serina Therapeutics (SER) disclose for its CFO?
Serina Therapeutics disclosed that CFO Gregory S. Curhan received a grant of stock options for 123,019 shares of common stock. These options are a compensation award, not an open-market purchase, and give the right to buy shares at a fixed exercise price.
What is the exercise price of the Serina Therapeutics CFO’s stock option grant?
The stock options granted to the Serina Therapeutics CFO have an exercise price of $1.89 per share. This means he can purchase up to 123,019 shares at $1.89, regardless of the market price, once the options are vested and exercisable.
How do the Serina Therapeutics CFO’s stock options vest over time?
The options vest over four years, with 12/48ths of the shares vesting twelve months after the Vesting Commencement Date. The remaining 1/48th of the shares vest on the same calendar day of each subsequent month until fully vested, assuming continued service.
When do the Serina Therapeutics CFO’s newly granted stock options expire?
The stock options granted to the Serina Therapeutics CFO expire on May 21, 2036. If not exercised by that expiration date, the right to buy the 123,019 underlying shares at $1.89 per share will lapse under the option’s terms.
Is the Serina Therapeutics CFO’s Form 4 transaction a stock purchase or a grant?
The Form 4 shows a grant or award acquisition of stock options, not an open-market stock purchase. The CFO received options to buy 123,019 shares at $1.89 per share as part of compensation, subject to the specified vesting schedule and expiration date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates